Filters

STAT5b(Ser731) Antibody

STAT5b(Ser731) Antibody size: 0.1ml 281

Supplier BIOSS PRIMARY UNCONJUGATED ANTIBODIES
Price 281
Size 0.1ml
Contact us Ask Component cell markers and DNA bp. markers are genetic markerser genes or DNA sequenceswith selection audit
Long nameSTAT5b(Ser731) Primary Polyclonal Antibody
Also known asSTAT5b(Ser731) PAb
CategoryPrimary Antibodies
ConjugationUnconjugated
Target AntigenSTAT5b Ser731
SpecificityThis is a highly specific antibody against STAT5b Ser731
Modification(s)Phosphorylation
Modification site(s)Ser731
ClonalityPolyclonal antibody
Clone numberPolyclonal antibody
Concentration1ug per 1ul
SourceKLH conjugated synthetic phosphopeptide derived from human STAT5b around the phosphorylation site of Ser731
Gene ID number6777
Tested Applications IF(IHC-P), IHC-P, WB
Recommended dilutions IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000)
Cross reactivity Mouse, Rat, Human
Cross reactive species details not every possible cross-reactivity is known, Due to limited amount of testing and knowledge
Background of the target antigen Binds to the GAS element and activates PRL-induced transcription, Carries out a dual function: signal transduction and activation of transcription
Purification methodThis antibody was purified via Protein A
Storage conditions 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA
Synonym names STA5B_HUMAN, STAT5, Signal transducer and activator of transcription 5B, Stat5b, Transcription factor STAT5B, STAT5bphospho S731
PropertiesC, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24°
Gene targetSTAT5b(Ser731)
Short nameSTAT5b(Ser731) Antibody
Technique antibodies against human proteins, antibodies for, Antibody
Alternative namesignal transducer and activator on transcription 5B(Ser731) (Antibody to)
Alternative techniqueantibodies

Similar products

Subscribe to our Newsletter